People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Progenics Pharmaceuticals Inc | — | Biotechnology | Series A | $12.9M | $467.2M | 2013 |
Robert J. Israel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert J. Israel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William C Olson | 1 | 3 |
| David A. Scheinberg | 1 | 2 |
| Paul J. Maddon | 1 | 2 |
| Peter J. Crowley | 1 | 2 |
| Charles A. Baker | 1 | 1 |
| Mark R. Baker | 1 | 1 |
| Kurt W. Briner | 1 | 1 |
| Nicole S. Williams | 1 | 1 |
| Stephen P. Goff | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.